EUVIMEDEUVIMED entdecken
Crossref

Evaluation of Ovarian Reserve and Pregnancy Outcomes Following Microsurgical Tuboplasty in Reproductive-Age Women: A Prospective Comparative Study

Monika Singla, Komal Bharti Singla, Pawan Goyal

International Journal of Current Pharmaceutical Review and Research · 30.06.2026 · 18 (06)

DOI: 10.25258/ijcpr.18.6.171 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.06.2026. Verfasst von Monika Singla und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tubal factor infertility remains a major reproductive problem, and the effect of reconstructive tubal surgery on ovarian reserve and subsequent pregnancy requires careful clinical evaluation.

Method

This prospective comparative study evaluated 80 reproductive-age women with tubal-factor infertility who either underwent microsurgical tuboplasty (n = 40) or received standard non-reconstructive fertility management after diagnostic laparoscopy (n = 40). Serum anti-Mullerian hormone (AMH), antral follicle count (AFC), day-2 follicle-stimulating hormone (FSH), ovarian volume, postoperative tubal patency, time to conception, clinical pregnancy, ectopic pregnancy, miscarriage, and live-birth/ongoing pregnancy rates were assessed over 12 months.

Results

Baseline characteristics were comparable between groups, including age (31.4 +/- 4.2 vs 32.0 +/- 4.1 years, p = 0.518), infertility duration (4.1 +/- 1.8 vs 4.4 +/- 1.9 years, p = 0.472), AMH (2.74 +/- 0.86 vs 2.69 +/- 0.81 ng/mL, p = 0.789), and AFC (11.6 +/- 3.9 vs 11.2 +/- 3.5, p = 0.631). At 6 months, AMH showed no clinically meaningful decline after tuboplasty (2.74 +/- 0.86 to 2.61 +/- 0.83 ng/mL, p = 0.091), and AFC remained stable (11.6 +/- 3.9 to 11.1 +/- 3.7, p = 0.173). Tubal patency was achieved in 32/40 women (80.0%) after tuboplasty. Clinical pregnancy occurred more often after tuboplasty than in controls (55.0% vs 25.0%, p = 0.006), with higher intrauterine pregnancy (50.0% vs 22.5%, p = 0.010) and live-birth/ongoing pregnancy rates (42.5% vs 17.5%, p = 0.015).

Conclusion

Microsurgical tuboplasty preserved short-term ovarian reserve and significantly improved spontaneous pregnancy outcomes in carefully selected reproductive-age women.

Zitieren

APA

Singla, M., Singla, K. B., & Goyal, P. (2026). Evaluation of Ovarian Reserve and Pregnancy Outcomes Following Microsurgical Tuboplasty in Reproductive-Age Women: A Prospective Comparative Study. International Journal of Current Pharmaceutical Review and Research, 18(06). https://doi.org/10.25258/ijcpr.18.6.171

Vancouver

Singla M, Singla KB, Goyal P. Evaluation of Ovarian Reserve and Pregnancy Outcomes Following Microsurgical Tuboplasty in Reproductive-Age Women: A Prospective Comparative Study. International Journal of Current Pharmaceutical Review and Research. 2026;18(06). doi:10.25258/ijcpr.18.6.171

BibTeX
@article{Singla2026,
  author = {Singla, Monika and Singla, Komal Bharti and Goyal, Pawan},
  title = {Evaluation of Ovarian Reserve and Pregnancy Outcomes Following Microsurgical Tuboplasty in Reproductive-Age Women: A Prospective Comparative Study},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {06},
  doi = {10.25258/ijcpr.18.6.171}
}
Kostenlos starten →